Bispecific Peptide Binds to VEGFR2 and Integrin αvβ3, Forming an Artificial Extracellular Matrix for Anti‐Ocular Neoangiogenesis
Small · 2025
DOI: 10.1002/smll.202409664 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, 2025. Verfasst von Ye Zhang und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, No.600 Yishan Road, Sha…. Hauptthemen laut MEDLINE: Peptides, Vascular Endothelial Growth Factor Receptor-2, Retinal Neovascularization, Extracellular Matrix. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 67 Literaturangaben. Gefördert von: National Science Fund for Distinguished Young Scholars, National Natural Science Foundation of China, China Postdoctoral Science Foundation.
Abstract (Originalsprache)
Ocular neovascularization (NV) leads to vision loss in various pathological conditions. Current therapies primarily inhibit vascular endothelial growth factor (VEGF) signaling; however, targeting additional pathways may improve outcomes. A bispecific peptide (BsPt) is developed that targets VEGFR2 and integrin αvβ3 to treat retinal neovascularization (RNV) and choroidal neovascularization (CNV) more effectively. BsPt binds to both receptors on endothelial cells (ECs) and forms nanofibrous networks on their surfaces, resulting in potent NV inhibition. In vitro, BsPt suppressed retinal EC migration and tube formation. Intravitreal BsPt injection outperformed aflibercept in mouse models of oxygen‐induced retinopathy (OIR) and laser‐induced CNV. RNA sequencing revealed that BsPt‐induced nanofibers upregulated extracellular matrix (ECM) and cell adhesion genes, which may contribute to anti‐angiogenesis and anti‐leakage effects. In summary, BsPt targeting VEGFR2 and integrin αvβ3 demonstrates enhanced therapeutic potential for RNV and CNV.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, No.600 Yishan Road, Shanghai, 200233, China.
- College of Biomedical Engineering, Chongqing Medical University, Chongqing, 400016, China.
- Department of Ophthalmology, Changsha Hospital of Traditional Chinese Medicine (Changsha Eighth Hospital), NO.22 Xingsha Avenue, Changsha, 410100, China.
- CAS Center for Excellence in Nanoscience, CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, National Center for Nanoscience and Technology (NCNST), No. 11 Beiyitiao, Zhongguancun, Beijing, 10019…
ORCID-Profile: Ye Zhang, Kuo Zhang, Lei Wang, Hao Wang, Da Long
Förderung
- National Science Fund for Distinguished Young Scholars
- National Natural Science Foundation of China
- China Postdoctoral Science Foundation
- The College-level Project Fund of Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
Zitieren
APA
Zhang, Y., Zhang, K., Xu, L., Lu, X., Hu, P., Long, J., Cui, N., Wu, X., Ye, Y., Xu, G. Y., Zhang, Q. S., Wang, L., Hu, Y., Wang, H., & Long, D. (2025). Bispecific Peptide Binds to VEGFR2 and Integrin αvβ3, Forming an Artificial Extracellular Matrix for Anti‐Ocular Neoangiogenesis. Small. https://doi.org/10.1002/smll.202409664
Vancouver
Zhang Y, Zhang K, Xu L, Lu X, Hu P, Long J, et al. Bispecific Peptide Binds to VEGFR2 and Integrin αvβ3, Forming an Artificial Extracellular Matrix for Anti‐Ocular Neoangiogenesis. Small. 2025. doi:10.1002/smll.202409664
BibTeX
@article{Zhang2025,
author = {Zhang, Ye and Zhang, Kuo and Xu, Ling and Lu, Xinmin and Hu, Ping and Long, Jinyi and Cui, Ning and Wu, Xue and Ye, Yuhong and Xu, Guo-Yang and Zhang, Qing-Shi and Wang, Lei and Hu, Ying and Wang, Hao and Long, Da},
title = {Bispecific Peptide Binds to VEGFR2 and Integrin αvβ3, Forming an Artificial Extracellular Matrix for Anti‐Ocular Neoangiogenesis},
journal = {Small},
year = {2025},
doi = {10.1002/smll.202409664}
}
EUVIMED